Drug Dose Adjustment in Dialysis Patients Admitted in Clinics Other Than Internal Medicine

Solak Y., Biyik Z., Gaipov A., Kayrak M., Ciray H., Cizmecioglu A., Tonbul H.Z.

Research output: Chapter in Book/Report/Conference proceedingChapter

1 Citation (Scopus)

Abstract

Many drugs that are administered during hospitalization are metabolized or excreted through kidneys, consequently require dosage adjustment. We aimed to investigate inappropriate prescription of drugs requiring renal dose adjustment (RDA) in various surgical and medical inpatient clinics. We retrospectively determined dialysis patients hospitalized between January 2007 and December 2010. Inpatient clinics, including cardiology, pulmonary medicine, neurology, infectious diseases (medical clinics) and cardiovascular surgery, orthopedics, general surgery, obstetrics and gynecology, and neurosurgery (surgical clinics), were screened via electronic database. Total and RDA medications were determined. RDA drugs correctly adjusted to creatinine clearance were labeled as RDA-A (appropriate), otherwise as RDA-I (inappropriate). Renal doses of RDA medications were based on the "American College of Physicians Drug Prescribing in Renal Failure, fifth Edition." Two hundred seventeen hospitalization records of 172 dialysis patients (92 men and 80 women) were included in the analysis. Mean age of patients was 59.4 +/- 14.6 years, and the mean hospitalization duration was 8.5 +/- 7.8 days. In total, 247 (84.3%, percentage in drugs requiring dose adjustment) and 175 (46.2%) drugs have been inadequately dosed in surgical and medical clinics, respectively. The percentage of patients to whom at least 1 RDA-I drug was ordered was 92% and 91.4% for surgical and medical clinics, respectively (P > 0.05). Nephrology consultation numbers were 8 (7.1%) in surgical and 32 (30.4%) in medical clinics. The most common RDA-I drugs were aspirin and famotidine. A significant portion of RDA drugs was ordered inappropriately both in surgical and medical clinics. Nephrology consultation rate was very low. Measures to increase physician awareness are required to improve results. Copyright © 2013 Wolters Kluwer Health, Inc. All rights reserved.
Original languageEnglish
Title of host publicationAmerican Journal of Therapeutics
Place of PublicationY. Solak, Nephrology Unit, Department of Internal Medicine, Karaman State Hospital, Karaman 70100, Turkey. E-mail: yalcinsolakmd@gmail.com
PublisherLippincott Williams and Wilkins (E-mail: kathiest.clai@apta.org)
Pagese68-e73
ISBN (Print)1075-2765
DOIs
Publication statusPublished - 2016

Publication series

NameAmerican Journal of Therapeutics
Volume23

Fingerprint

Internal Medicine
Dialysis
Kidney
Pharmaceutical Preparations
Hospitalization
Nephrology
Inpatients
Referral and Consultation
Inappropriate Prescribing
Famotidine
Physicians
Drug Prescriptions
Pulmonary Medicine
Prescription Drugs
Neurosurgery
Neurology
Cardiology
Gynecology
Aspirin
Obstetrics

Keywords

  • *drug dosage form
  • *hemodialysis patient
  • *internal medicine
  • acetylsalicylic acid
  • adult
  • awareness
  • cardiology
  • cardiovascular surgery
  • college
  • communicable disease
  • consultation
  • creatinine clearance
  • data base
  • famotidine
  • female
  • general surgery
  • gynecology
  • hospital patient
  • hospitalization
  • human
  • inappropriate prescribing
  • information processing
  • kidney failure
  • major clinical study
  • male
  • nephrology
  • neurology
  • neurosurgery
  • obstetrics
  • orthopedics
  • physician
  • pulmonology
  • surgery

Cite this

Y., S., Z., B., A., G., M., K., H., C., A., C., & H.Z., T. (2016). Drug Dose Adjustment in Dialysis Patients Admitted in Clinics Other Than Internal Medicine. In American Journal of Therapeutics (pp. e68-e73). (American Journal of Therapeutics; Vol. 23). Y. Solak, Nephrology Unit, Department of Internal Medicine, Karaman State Hospital, Karaman 70100, Turkey. E-mail: yalcinsolakmd@gmail.com: Lippincott Williams and Wilkins (E-mail: kathiest.clai@apta.org). https://doi.org/10.1097/MJT.0b013e3182a4ef81

Drug Dose Adjustment in Dialysis Patients Admitted in Clinics Other Than Internal Medicine. / Y., Solak; Z., Biyik; A., Gaipov; M., Kayrak; H., Ciray; A., Cizmecioglu; H.Z., Tonbul.

American Journal of Therapeutics. Y. Solak, Nephrology Unit, Department of Internal Medicine, Karaman State Hospital, Karaman 70100, Turkey. E-mail: yalcinsolakmd@gmail.com : Lippincott Williams and Wilkins (E-mail: kathiest.clai@apta.org), 2016. p. e68-e73 (American Journal of Therapeutics; Vol. 23).

Research output: Chapter in Book/Report/Conference proceedingChapter

Y., S, Z., B, A., G, M., K, H., C, A., C & H.Z., T 2016, Drug Dose Adjustment in Dialysis Patients Admitted in Clinics Other Than Internal Medicine. in American Journal of Therapeutics. American Journal of Therapeutics, vol. 23, Lippincott Williams and Wilkins (E-mail: kathiest.clai@apta.org), Y. Solak, Nephrology Unit, Department of Internal Medicine, Karaman State Hospital, Karaman 70100, Turkey. E-mail: yalcinsolakmd@gmail.com, pp. e68-e73. https://doi.org/10.1097/MJT.0b013e3182a4ef81
Y. S, Z. B, A. G, M. K, H. C, A. C et al. Drug Dose Adjustment in Dialysis Patients Admitted in Clinics Other Than Internal Medicine. In American Journal of Therapeutics. Y. Solak, Nephrology Unit, Department of Internal Medicine, Karaman State Hospital, Karaman 70100, Turkey. E-mail: yalcinsolakmd@gmail.com: Lippincott Williams and Wilkins (E-mail: kathiest.clai@apta.org). 2016. p. e68-e73. (American Journal of Therapeutics). https://doi.org/10.1097/MJT.0b013e3182a4ef81
Y., Solak ; Z., Biyik ; A., Gaipov ; M., Kayrak ; H., Ciray ; A., Cizmecioglu ; H.Z., Tonbul. / Drug Dose Adjustment in Dialysis Patients Admitted in Clinics Other Than Internal Medicine. American Journal of Therapeutics. Y. Solak, Nephrology Unit, Department of Internal Medicine, Karaman State Hospital, Karaman 70100, Turkey. E-mail: yalcinsolakmd@gmail.com : Lippincott Williams and Wilkins (E-mail: kathiest.clai@apta.org), 2016. pp. e68-e73 (American Journal of Therapeutics).
@inbook{b6704417e7a24e91aa2ac444d5a52888,
title = "Drug Dose Adjustment in Dialysis Patients Admitted in Clinics Other Than Internal Medicine",
abstract = "Many drugs that are administered during hospitalization are metabolized or excreted through kidneys, consequently require dosage adjustment. We aimed to investigate inappropriate prescription of drugs requiring renal dose adjustment (RDA) in various surgical and medical inpatient clinics. We retrospectively determined dialysis patients hospitalized between January 2007 and December 2010. Inpatient clinics, including cardiology, pulmonary medicine, neurology, infectious diseases (medical clinics) and cardiovascular surgery, orthopedics, general surgery, obstetrics and gynecology, and neurosurgery (surgical clinics), were screened via electronic database. Total and RDA medications were determined. RDA drugs correctly adjusted to creatinine clearance were labeled as RDA-A (appropriate), otherwise as RDA-I (inappropriate). Renal doses of RDA medications were based on the {"}American College of Physicians Drug Prescribing in Renal Failure, fifth Edition.{"} Two hundred seventeen hospitalization records of 172 dialysis patients (92 men and 80 women) were included in the analysis. Mean age of patients was 59.4 +/- 14.6 years, and the mean hospitalization duration was 8.5 +/- 7.8 days. In total, 247 (84.3{\%}, percentage in drugs requiring dose adjustment) and 175 (46.2{\%}) drugs have been inadequately dosed in surgical and medical clinics, respectively. The percentage of patients to whom at least 1 RDA-I drug was ordered was 92{\%} and 91.4{\%} for surgical and medical clinics, respectively (P > 0.05). Nephrology consultation numbers were 8 (7.1{\%}) in surgical and 32 (30.4{\%}) in medical clinics. The most common RDA-I drugs were aspirin and famotidine. A significant portion of RDA drugs was ordered inappropriately both in surgical and medical clinics. Nephrology consultation rate was very low. Measures to increase physician awareness are required to improve results. Copyright {\circledC} 2013 Wolters Kluwer Health, Inc. All rights reserved.",
keywords = "*drug dosage form, *hemodialysis patient, *internal medicine, acetylsalicylic acid, adult, awareness, cardiology, cardiovascular surgery, college, communicable disease, consultation, creatinine clearance, data base, famotidine, female, general surgery, gynecology, hospital patient, hospitalization, human, inappropriate prescribing, information processing, kidney failure, major clinical study, male, nephrology, neurology, neurosurgery, obstetrics, orthopedics, physician, pulmonology, surgery",
author = "Solak Y. and Biyik Z. and Gaipov A. and Kayrak M. and Ciray H. and Cizmecioglu A. and Tonbul H.Z.",
year = "2016",
doi = "10.1097/MJT.0b013e3182a4ef81",
language = "English",
isbn = "1075-2765",
series = "American Journal of Therapeutics",
publisher = "Lippincott Williams and Wilkins (E-mail: kathiest.clai@apta.org)",
pages = "e68--e73",
booktitle = "American Journal of Therapeutics",

}

TY - CHAP

T1 - Drug Dose Adjustment in Dialysis Patients Admitted in Clinics Other Than Internal Medicine

AU - Y., Solak

AU - Z., Biyik

AU - A., Gaipov

AU - M., Kayrak

AU - H., Ciray

AU - A., Cizmecioglu

AU - H.Z., Tonbul

PY - 2016

Y1 - 2016

N2 - Many drugs that are administered during hospitalization are metabolized or excreted through kidneys, consequently require dosage adjustment. We aimed to investigate inappropriate prescription of drugs requiring renal dose adjustment (RDA) in various surgical and medical inpatient clinics. We retrospectively determined dialysis patients hospitalized between January 2007 and December 2010. Inpatient clinics, including cardiology, pulmonary medicine, neurology, infectious diseases (medical clinics) and cardiovascular surgery, orthopedics, general surgery, obstetrics and gynecology, and neurosurgery (surgical clinics), were screened via electronic database. Total and RDA medications were determined. RDA drugs correctly adjusted to creatinine clearance were labeled as RDA-A (appropriate), otherwise as RDA-I (inappropriate). Renal doses of RDA medications were based on the "American College of Physicians Drug Prescribing in Renal Failure, fifth Edition." Two hundred seventeen hospitalization records of 172 dialysis patients (92 men and 80 women) were included in the analysis. Mean age of patients was 59.4 +/- 14.6 years, and the mean hospitalization duration was 8.5 +/- 7.8 days. In total, 247 (84.3%, percentage in drugs requiring dose adjustment) and 175 (46.2%) drugs have been inadequately dosed in surgical and medical clinics, respectively. The percentage of patients to whom at least 1 RDA-I drug was ordered was 92% and 91.4% for surgical and medical clinics, respectively (P > 0.05). Nephrology consultation numbers were 8 (7.1%) in surgical and 32 (30.4%) in medical clinics. The most common RDA-I drugs were aspirin and famotidine. A significant portion of RDA drugs was ordered inappropriately both in surgical and medical clinics. Nephrology consultation rate was very low. Measures to increase physician awareness are required to improve results. Copyright © 2013 Wolters Kluwer Health, Inc. All rights reserved.

AB - Many drugs that are administered during hospitalization are metabolized or excreted through kidneys, consequently require dosage adjustment. We aimed to investigate inappropriate prescription of drugs requiring renal dose adjustment (RDA) in various surgical and medical inpatient clinics. We retrospectively determined dialysis patients hospitalized between January 2007 and December 2010. Inpatient clinics, including cardiology, pulmonary medicine, neurology, infectious diseases (medical clinics) and cardiovascular surgery, orthopedics, general surgery, obstetrics and gynecology, and neurosurgery (surgical clinics), were screened via electronic database. Total and RDA medications were determined. RDA drugs correctly adjusted to creatinine clearance were labeled as RDA-A (appropriate), otherwise as RDA-I (inappropriate). Renal doses of RDA medications were based on the "American College of Physicians Drug Prescribing in Renal Failure, fifth Edition." Two hundred seventeen hospitalization records of 172 dialysis patients (92 men and 80 women) were included in the analysis. Mean age of patients was 59.4 +/- 14.6 years, and the mean hospitalization duration was 8.5 +/- 7.8 days. In total, 247 (84.3%, percentage in drugs requiring dose adjustment) and 175 (46.2%) drugs have been inadequately dosed in surgical and medical clinics, respectively. The percentage of patients to whom at least 1 RDA-I drug was ordered was 92% and 91.4% for surgical and medical clinics, respectively (P > 0.05). Nephrology consultation numbers were 8 (7.1%) in surgical and 32 (30.4%) in medical clinics. The most common RDA-I drugs were aspirin and famotidine. A significant portion of RDA drugs was ordered inappropriately both in surgical and medical clinics. Nephrology consultation rate was very low. Measures to increase physician awareness are required to improve results. Copyright © 2013 Wolters Kluwer Health, Inc. All rights reserved.

KW - drug dosage form

KW - hemodialysis patient

KW - internal medicine

KW - acetylsalicylic acid

KW - adult

KW - awareness

KW - cardiology

KW - cardiovascular surgery

KW - college

KW - communicable disease

KW - consultation

KW - creatinine clearance

KW - data base

KW - famotidine

KW - female

KW - general surgery

KW - gynecology

KW - hospital patient

KW - hospitalization

KW - human

KW - inappropriate prescribing

KW - information processing

KW - kidney failure

KW - major clinical study

KW - male

KW - nephrology

KW - neurology

KW - neurosurgery

KW - obstetrics

KW - orthopedics

KW - physician

KW - pulmonology

KW - surgery

UR - http://www.lww.com/store/products?1075-2765

UR - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed18a&NEWS=N&AN=52749915

UR - http://www.mendeley.com/research/drug-dose-adjustment-dialysis-patients-admitted-clinics-other-internal-medicine-1

U2 - 10.1097/MJT.0b013e3182a4ef81

DO - 10.1097/MJT.0b013e3182a4ef81

M3 - Chapter

SN - 1075-2765

T3 - American Journal of Therapeutics

SP - e68-e73

BT - American Journal of Therapeutics

PB - Lippincott Williams and Wilkins (E-mail: kathiest.clai@apta.org)

CY - Y. Solak, Nephrology Unit, Department of Internal Medicine, Karaman State Hospital, Karaman 70100, Turkey. E-mail: yalcinsolakmd@gmail.com

ER -